Compounds > 1-hydroxy-3-amino-2-pyrrolidone
Page last updated: 2024-10-21

1-hydroxy-3-amino-2-pyrrolidone and Brain Diseases

1-hydroxy-3-amino-2-pyrrolidone has been researched along with Brain Diseases in 1 studies

1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source

Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McDonald, JW1
Uckele, J1
Silverstein, FS1
Johnston, MV1

Other Studies

1 other study available for 1-hydroxy-3-amino-2-pyrrolidone and Brain Diseases

ArticleYear
HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage.
    Neuroscience letters, 1989, Sep-25, Volume: 104, Issue:1-2

    Topics: Animals; Animals, Newborn; Aspartic Acid; Brain Diseases; Corpus Striatum; N-Methylaspartate; Oxadia

1989